Corporate

Practice

Filters

Biotie acquisition by Acorda

Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc…

Biotie acquisition by Acorda

Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc…

Ardelyx, Inc. Common Stock Offering

Davis Polk advised the joint book-running managers in connection with an $86.2 million SEC-registered follow-on common stock…

Ardelyx, Inc. Common Stock Offering

Davis Polk advised the joint book-running managers in connection with an $86.2 million SEC-registered follow-on common stock…
Back to top